Ceribell vs Octagos
Ceribell trades on Nasdaq as CBLL, and its second-quarter 2026 release, a vendor document, reports $28.1 million in revenue and 712 active accounts. Octagos is a Houston company led by an electrophysiologist, Shanti Bansal, MD, and its site states no legal entity, funding or founding year.
An intensive care unit running EEG monitoring is Ceribell's customer, and a cardiology practice with implanted device transmissions to triage is Octagos's, so the two sell to different clinical teams. Ceribell's homepage cites FedRAMP High authorization, and its compliance declaration page covers a California healthcare compliance program and does not state HIPAA or SOC 2. Octagos's homepage says HIPAA compliant, SOC 2 Type 2 and SOC 3 certified, on Microsoft Azure.
For evidence, Ceribell's PubMed record includes the DECIDE multicenter prospective study of rapid-response EEG (Critical Care Medicine, 2020). Octagos points to an Octagos-linked 2025 JACC Advances paper, and the vendor's AI overview page says the paper covers 690,673 transmissions and reports 99.1% sensitivity against 70.8% for technicians.
Decision support · Reviewed November 2, 2026
When to pick each one
Ceribell
- Nasdaq-listed, second-quarter 2026 revenue $28.1M, vendor-reported
- AI seizure detection at the bedside
- FedRAMP High authorization, vendor-stated
Octagos
- Vendor states SOC 2 Type 2 and SOC 3
- Cardiac device triage with named EHRs
- Founder is a practicing electrophysiologist
Score
Each row shows points earned of points available under the published rubric.
Ceribell
49of 100
Octagos
43of 100
| Dimension | Ceribell | Octagos | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 4.8 / 4.8 | -4.8 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 14.7 / 21 | 0 |
| RCT / meta-analysis / systematic review | 4.5 / 9 | 0 / 9 | +4.5 |
| Funding & adoption signal | 8.4 / 12 | 3 / 12 | +5.4 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Ceribell
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Purchase terms: one-year initial term, auto-renewing yearly unless 90 days notice. |
Octagos
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Ceribell
FDA decisions
K261712 (opens in new tab)510(k)2026-09-16
Ceribell EEG Analysis Software
K261101 (opens in new tab)510(k)2026-06-30
Ceribell Monitor
K260998 (opens in new tab)510(k)2026-06-24
Ceribell Neurology Review Software
K260363 (opens in new tab)510(k)2026-04-03
Ceribell Brain Monitor Headband
K254033 (opens in new tab)510(k)2026-02-09
Ceribell Instant EEG Headset
Show 11 more
K251936 (opens in new tab)510(k)2025-12-08
Ceribell Delirium Monitor System
K252070 (opens in new tab)510(k)2025-11-21
Ceribell Infant Seizure Detection Software
K251381 (opens in new tab)510(k)2025-10-31
Ceribell Instant EEG Headcap
K241589 (opens in new tab)510(k)2025-04-09
Ceribell Seizure Detection Software
K232052 (opens in new tab)510(k)2023-08-08
Ceribell Instant EEG Headband
K223504 (opens in new tab)510(k)2023-05-23
Ceribell Status Epilepticus Monitor
K223086 (opens in new tab)510(k)2023-03-22
Ceribell Instant EEG Headcap
K210805 (opens in new tab)510(k)2021-08-30
Ceribell Instant EEG Headband
K191301 (opens in new tab)510(k)2019-09-11
Ceribell Pocket EEG Device
K171459 (opens in new tab)510(k)2017-08-21
Ceribell Instant EEG Headband
K170363 (opens in new tab)510(k)2017-05-08
Ceribell Pocket EEG Device
Peer-reviewed
4 PubMed records name Ceribell.
- Automated Seizure Detection in Patients with Cardiac Arrest: A Retrospective Review of Ceribell™ Rapid-EEG Recordings. (opens in new tab)
- Point-of-Care EEG Artificial Intelligence Measure of Seizure Burden Associates With Clinical Outcome at Discharge. (opens in new tab)
- Assessing the performance of artificial intelligence in detecting electrographic status epilepticus when human experts often disagree. (opens in new tab)
Octagos
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
2 PubMed records name Octagos.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Ceribell | Octagos |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, Oracle Health, athenahealth, medent, NextGen |
| Founded | n/a | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.